Dr. Allen Hunt

Family Medicine
Lincoln Physician Network LLC
3910 Village Dr, 
Lincoln, NE 
Lincoln Physician Network LLC
3910 Village Dr, 
Lincoln, NE 

Overview

Allen Hunt is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska.

His clinical expertise encompasses Asthma and Tracheitis.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 9 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in NE

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

Lincoln Physician Network LLC
3910 Village Dr, Lincoln, NE 68516
Other Locations
Horisun Hospice
8055 O St Ste 300, Lincoln, NE 68510

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SM17 When Administered Intravenously as a Single Ascending Dose in Healthy Subjects (Part A) and as Multiple Ascending Doses in Healthy Subjects (Part B)
A Phase 1, First-in-Human, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SM17 When Administered Intravenously as a Single Ascending Dose in Healthy Subjects (Part A) and as Multiple Ascending Doses in Healthy Subjects (Part B)
Enrollment Status: Completed
Publish Date: September 27, 2024
Intervention Type: Other, Biological
Study Phase: Phase 1
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole and Mefenamic Acid on the Single-Dose Pharmacokinetic Profile of Soticlestat in Healthy Participants
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole and Mefenamic Acid on the Single-Dose Pharmacokinetic Profile of Soticlestat in Healthy Participants
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Double-blind, Randomized, Placebo-controlled, Sequential, Single, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Parameters of Subcutaneous Injections of GZR18 in Healthy Subjects
A Double-blind, Randomized, Placebo-controlled, Sequential, Single, Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Parameters of Subcutaneous Injections of GZR18 in Healthy Subjects
Enrollment Status: Completed
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 1
A Phase I, Open-Label, Randomized, Three-Period, Three-Sequence Crossover Study of the Effects of Co-administration of Intravenous VLX-1005 With Argatroban on Pharmacokinetics, Pharmacodynamics and Safety in Healthy Adult Subjects
A Phase I, Open-Label, Randomized, Three-Period, Three-Sequence Crossover Study of the Effects of Co-administration of Intravenous VLX-1005 With Argatroban on Pharmacokinetics, Pharmacodynamics and Safety in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: January 11, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous VLX-1005 in Healthy Subjects
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Intravenous VLX-1005 in Healthy Subjects
Enrollment Status: Completed
Publish Date: April 28, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of Single Ascending Doses of Subcutaneous CDX-0159 to Assess the Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of Single Ascending Doses of Subcutaneous CDX-0159 to Assess the Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
Enrollment Status: Completed
Publish Date: January 21, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Study to Assess Absolute Bioavailability of TAK-994 and to Characterize Mass Balance, Pharmacokinetics, Absorption, Metabolism, and Excretion of [14C]TAK-994 in Male Healthy Subjects
A Phase 1 Study to Assess Absolute Bioavailability of TAK-994 and to Characterize Mass Balance, Pharmacokinetics, Absorption, Metabolism, and Excretion of [14C]TAK-994 in Male Healthy Subjects
Enrollment Status: Completed
Publish Date: June 29, 2021
Intervention Type: Drug
Study Phase: Phase 1
Exploratory Microdose Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
Exploratory Microdose Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

8 Total Publications

The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects.
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects.
Journal: Diabetes, obesity & metabolism
Published: November 04, 2024
Similar Doctors
Expertise in
18
conditions
Dr. Ruilin Wang
Family Medicine
Expertise in
18
conditions
Dr. Ruilin Wang
Family Medicine

South Lincoln Family Physicians PC

4424 S 86th St, 
Lincoln, NE 
 (3.4 miles away)
402-483-8500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ruilin Wang is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Wang is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Chronic Erosive Gastritis, Osteomyelitis in Children, Gastritis, Infant Hyperglycemia, and Vertebroplasty.

Expertise in
19
conditions
Dr. Michelle Ellis
Family Medicine
Expertise in
19
conditions
Dr. Michelle Ellis
Family Medicine

CHI Health Clinic Family Medicine (Prairie Lake)

8445 Andermatt Dr, 
Lincoln, NE 
 (3.3 miles away)
402-328-4700
Languages Spoken:
English
See accepted insurances

Michelle Ellis is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Ellis is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Anemia, Urinary Tract Infection in Children, and High Cholesterol. Dr. Ellis is board certified in Family Medicine - American Board Of Family Medicine.

Expertise in
13
conditions
Dr. Nathan Denell
Family Medicine
Expertise in
13
conditions
Dr. Nathan Denell
Family Medicine

South Lincoln Family Physicians PC

3201 Pioneers Blvd Ste 304, 
Lincoln, NE 
 (2.8 miles away)
402-483-2987
Languages Spoken:
English
See accepted insurances

Nathan Denell is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Denell is highly rated in 13 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis.

Frequently Asked Questions about Dr. Allen Hunt

How do I make an appointment with Dr. Allen Hunt?

You can book an appointment with Dr. Allen Hunt by calling their office at 402-434-7383. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Allen Hunt a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Allen Hunt is classified as an Experienced expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Allen Hunt specialize in?

While Dr. Allen Hunt is a Family Medicine, they have specific expertise in Asthma, Tracheitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Allen Hunt participate in research or clinical trials?

Yes. Dr. Allen Hunt has published 8 articles and abstracts on conditions like Asthma. You can view a list of Dr. Allen Hunt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Allen Hunt accept my insurance?

Dr. Allen Hunt accepts most major insurance plans, including Blue Cross Blue Shield and Health Net. We recommend calling the office directly at 402-434-7383 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hunt's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile